Free Trial

Craneware (CRW) Competitors

Craneware logo
GBX 2,472.50 -7.50 (-0.30%)
As of 09:50 AM Eastern

CRW vs. EMIS, INS, KOO, RENX, COG, INHC, FDBK, IQAI, TRLS, and DVRG

Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.

Craneware vs. Its Competitors

Craneware (LON:CRW) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.

Company Net Margins Return on Equity Return on Assets
Craneware6.18% 3.58% 2.28%
EMIS Group 17.23%23.17%7.99%

Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, EMIS Group has a beta of -0.13, indicating that its stock price is 113% less volatile than the S&P 500.

EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Craneware£230.77M4.60£14.27M£27.0791.35
EMIS Group£176.86M0.00£30.48M£0.47N/A

Craneware currently has a consensus price target of GBX 2,725, indicating a potential upside of 10.21%. Given Craneware's stronger consensus rating and higher possible upside, equities analysts clearly believe Craneware is more favorable than EMIS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Craneware
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
EMIS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

60.2% of Craneware shares are held by institutional investors. Comparatively, 105.6% of EMIS Group shares are held by institutional investors. 19.3% of Craneware shares are held by insiders. Comparatively, 3.6% of EMIS Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Craneware had 6 more articles in the media than EMIS Group. MarketBeat recorded 6 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 0.44 beat EMIS Group's score of 0.00 indicating that Craneware is being referred to more favorably in the media.

Company Overall Sentiment
Craneware Neutral
EMIS Group Neutral

Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.2%. EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays out 107.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Craneware beats EMIS Group on 11 of the 17 factors compared between the two stocks.

Get Craneware News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRW vs. The Competition

MetricCranewareHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.06B£226.03M£5.53B£3.02B
Dividend Yield1.44%5.90%3.80%5.02%
P/E Ratio91.35395.0528.09167.30
Price / Sales4.60235.22441.07284,030.82
Price / Cash14.7247.1435.8427.97
Price / Book2.655.248.214.47
Net Income£14.27M-£15.55M£3.24B£5.90B
7 Day Performance11.37%1.76%1.81%3.19%
1 Month Performance18.87%0.20%8.42%12.64%
1 Year Performance0.92%14.34%30.64%67.42%

Craneware Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRW
Craneware
2.0422 of 5 stars
GBX 2,472.50
-0.3%
GBX 2,725
+10.2%
+2.9%£1.06B£230.77M91.35734News Coverage
Analyst Forecast
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.2292 of 5 stars
GBX 191
+0.8%
GBX 456.67
+139.1%
-37.5%£70.10M£50.72M17.94478
RENX
Renalytix
N/AGBX 6.80
+0.7%
N/A-43.5%£28.19M£9.22M-0.32102Gap Down
COG
Cambridge Cognition
N/AGBX 33.44
+2.9%
N/A-27.5%£14M£15.64M-8.8980Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/AN/A£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 14
-3.4%
N/A-76.9%£6.13M£3.88M-0.5724Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.3%£1.77M£538.19K-13.676Gap Up
TRLS
Trellus Health
N/AGBX 0.70
+16.7%
N/A-67.2%£1.35M£65.83K-0.2031Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073

Related Companies and Tools


This page (LON:CRW) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners